Sodium-Dependent Glucose Transporter Type 2 Inhibitors as a Breakthrough in Neutropenia and Neutrophil Dysfunction Management in Patients with Glycogen Storage Disease Type Ib
Glycogen storage disease type Ib (GSD Ib) is a rare and extremely severe disease included in the group of hereditary carbohydrate metabolism disorders. The condition is caused by pathogenic variants in the SLC37A4 gene leading to glucose metabolic disorder in the liver and kidneys, and as a result t...
Saved in:
Main Authors: | Andrey N. Surkov (Author), Leyla S. Namazova-Baranova (Author), Anna L. Arakelyan (Author), Evgeny E. Bessonov (Author), Natalia V. Zhurkova (Author) |
---|---|
Format: | Book |
Published: |
"Paediatrician" Publishers LLC,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycogen storage disease type Ib: modern understanding of the pathogenesis of neutropenia and prospects for its treatment with empagliflozin
by: Andrej N. Surkov, et al.
Published: (2023) -
Glycogen Storage Disease Type Ib: The First Case in Taiwan
by: Hui-Ju Hsiao, et al.
Published: (2009) -
A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia
by: Fengyu Wang, et al.
Published: (2021) -
Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib
by: Caiqi Du, et al.
Published: (2021) -
Management of Children with Glycogen Storage Disease (Liver Involvement Forms). Best Practice Guidelines
by: Alexander A. Baranov, et al.
Published: (2020)